Laurie Toich, Assistant Editor

Investigational vaccine inhibits euphoria associated with heroin use.

Opioids have caused more than 70% of health events among patients with drug use disorder around the world.

Top news of the day from across the healthcare landscape.

Jason Westin, MD, an oncologist running for Congress, discusses the importance of stakeholder input for healthcare reform.​

Patients with obstructive sleep apnea and type 2 diabetes have an increased risk of retinopathy.

Racial and ethnic disparities closely linked to cost and value of care.

CDKL5 Disorder is characterized by seizures and neuro-developmental impairment.

Bills introduced at the state level would increase provider accountability for controlled substances.

Women who breastfed for at least 2 years reduced the risk of heart disease by 18% and stroke by 17%.

Patentiflorin A better inhibited viral replication than azidothymidine, which could lead to an HIV cure.

Top news of the day from across the healthcare landscape.

Filgrastim-sndz (Zarxio) is covered by 94% of employer-sponsored health plans.

Abemaciclib is a CDK4/6 inhibitor being explored in advanced breast cancer.

Abemaciclib is a cyclin-dependent kinase 4 and 6 inhibitor for advanced breast cancer.

Clinical trials to begin for an investigational approach to treating glioma.

Children diagnosed with diabetic ketoacidosis and type 1 diabetes may have higher HbA1C levels.

Approach using the cold virus and stem cell treatment targets brain tumors.

Modifying blood stem cells could turn off the immune response to an allergen.

Top healthcare news of the day from across the healthcare landscape.

Initial applications for insurer participation in 2018 dropped 38% from 2017.

A microneedle patch allows the flu vaccine to be safely and effectively self-administered.

More than 80% of patients with chronic urticaria report quality of life issues.

New York Senate passes bill to charge drug dealers with homicide for opioid-related deaths.

Top news of the day from across the healthcare landscape.

A diabetes wearable device can measure cortisol, glucose, and interleukin-6 in sweat to track disease progession.

VNS Therapy system is an implanted device that prevents seizures in patients with drug-resistant epilepsy.

DigniCap Cooling System approved for use among patients with solid tumors treated with certain types of chemotherapy.

Abatacept (Orencia) receives approval for third autoimmune condition.

Prembrolizumab (Keytruda) combination observed to have a high mortality rate.

Orencia has already been approved for two other autoimmune conditions.